lilac: comparing cardiac safety of abp 980 with trastuzumab
Published 4 years ago • 1.2K plays • Length 2:43Download video MP4
Download video MP3
Similar videos
-
3:14
abp 980, a trastuzumab biosimilar in combination with pertuzumab
-
5:33
results from the lilac study of abp 980 with trastuzumab for her2 early breast cancer
-
1:17
dr. kolberg discusses the lilac study of abp 980
-
4:49
abp 980, a biosimilar antibody for trastuzumab
-
1:56
dr. kolberg on the lilac study in breast cancer
-
15:30
in8bio
-
2:51
how india is making cancer care affordable | bbc news india
-
34:03
afib ablation: what you need to know!
-
1:51
impella® heart pump animation: for physicians
-
1:15
dr. kolberg discusses the central pathology review of abp 980
-
0:32
what can biosimilars offer us?
-
0:31
tavr procedure offers hope and options for patients - lila's good health
-
7:09
abemaciclib for hr-positive metastatic breast cancer
-
6:17
sara tolaney, sabcs 2022: adjuvant paclitaxel and trastuzumab for node-negative her2 breast cancer
-
2:17
dr. kolberg explains the approval process for biosimilars
-
6:05
implications for treating aml with cc-486
-
3:15
the unicancer-neopal study of letrozole and palbociclib in luminal cancer
-
1:02
dr. kolberg discusses next steps with abp 980
-
6:00
frontline pertuzumab for metastatic breast cancer
-
1:12
monarche: adjuvant abemaciclib in hr breast cancer
-
4:11
brca breast cancer: managing patients on parp inhibitors